Akums Drugs & Pharmaceuticals

quarterly
yearly
ParticularsJun '23Mar '24Jun '24
Revenue336.01325.01343.46
Expenses514.34372.77289.18
EBITDA-166.75-33.8769.86
EBIT-174.15-44.2460.48
Profit Before Tax-178.32-49.0454.28
Net Profit-189.67-57.8741.88
Financial Ratios
Operating Profit Margin-52.83%-11.78%22.02%
Net Profit Margin-60.10%-19.04%13.20%
Earning Per Share (Diluted)-13.26-4.042.93
Dividends Per Share0.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.3.9
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ